KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Times Interest Earned (2016 - 2026)

West Pharmaceutical Services has reported Times Interest Earned over the past 18 years, most recently at $93.21 for Q1 2026.

  • Quarterly Times Interest Earned fell 65.15% to $93.21 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $327.5 through Mar 2026, up 6.39% year-over-year, with the annual reading at $1169.8 for FY2025, 515.79% up from the prior year.
  • Times Interest Earned was $93.21 for Q1 2026 at West Pharmaceutical Services, up from -$783.0 in the prior quarter.
  • Over five years, Times Interest Earned peaked at $1537.0 in Q2 2025 and troughed at -$783.0 in Q4 2025.
  • The 5-year median for Times Interest Earned is $84.64 (2022), against an average of $167.76.
  • Peak annual rise in Times Interest Earned hit 1726.86% in 2025, while the deepest fall reached 292.48% in 2025.
  • Tracing WST's Times Interest Earned over 5 years: stood at $76.29 in 2022, then surged by 75.75% to $134.08 in 2023, then plummeted by 248.79% to -$199.5 in 2024, then crashed by 292.48% to -$783.0 in 2025, then soared by 111.9% to $93.21 in 2026.
  • According to Business Quant data, Times Interest Earned over the past three periods came in at $93.21, -$783.0, and $838.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.